mardi 13 septembre 2016

Onco Actu du 13 septembre 2016

2. Etiologie

How ionising radiation damages DNA and causes cancer [Sanger]

3.1 Tabac

FDA skepticism greets Pfizer's latest bid to escape the Chantix black box [FiercePharma]

FDA reviewers question Pfizer study about safety of its Chantix smoking cessation pill [STAT]

Cardiovascular Consequences of Childhood Secondhand Tobacco Smoke Exposure: Prevailing Evidence, Burden, and Racial and Socioeconomic Disparities: A Scientific Statement From the American Heart Association [Circulation]

Second-hand smoke can hurt kids years after exposure [Reuters]

4.12 Biopsies liquides

Biocept to Study Liquid Biopsy Platform in Bladder, Prostate Cancers [GEN]

4.5 Dép., diag. & prono. - Colorectal

As radiologists push for “virtual” colonoscopy coverage, risk of misleading readers is real [HealthNewsReview]

5. Traitements

Crashing cancer’s backup system – our progress so far [Cancer Research UK]

5.12.1 Immunothérapies - partenariats

Top 15 Immuno-Oncology Collaborations [GEN]

5.2.1 Pharma - Partenariats

Stanford inks computer-driven liver cancer drug discovery pact with twoXAR [FierceBiotech]

5.2.3 Pharma - économie

CRISPR cuts out $90M IPO bid as another gene editing biotech goes public [FierceBiotech]

5.4 Traitements - Economie

Bristol-Myers Squibb’s Response to ICER’s Call for Improvements to its Value Assessment Framework [BMS]

6. Lutte contre les cancers

Precision Oncology Isn’t Quite There Yet [In the Pipeline]

6.1 Observation

Cancer overtakes heart disease as Australia's biggest killer [Reuters]

6.10.1 Politiques (USA)

Data Sharing: Key Challenge for Cancer Moonshot (& American Health) [Technonomy]

6.6 Publications

Why Persistent Identifiers Deserve Their Own Festival [The Scholarly Kitchen]

6.7 DMP, Big Data & applis

Sharing personal health information can never be risk-free, but it can be low-risk [STAT]